Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates.
about
Effects of gastric bypass surgery on female reproductive functionModifiable Risk Factors and Infertility: What are the Connections?Obesity and reproductive functionHealth and fertility in World Health Organization group 2 anovulatory womenHair mercury concentrations and in vitro fertilization (IVF) outcomes among women from a fertility clinicPredictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination.Effect of parental physiological conditions and assisted reproductive technologies on the pregnancy and birth outcomes in infertile patients.Endoplasmic reticulum (ER) stress in cumulus-oocyte complexes impairs pentraxin-3 secretion, mitochondrial membrane potential (DeltaPsi m), and embryo development.Minireview: Metabolism of female reproduction: regulatory mechanisms and clinical implicationsOutcome of assisted reproductive technology in overweight and obese women.A prediction model for live birth and multiple births within the first three cycles of assisted reproductive technology.Preconception counseling in couples undergoing fertility treatment.Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation.Body mass index and pregnancy outcome after assisted reproduction treatment.The impact of obesity on egg qualityMetabolic control of oocyte development: linking maternal nutrition and reproductive outcomesApplication of a validated prediction model for in vitro fertilization: comparison of live birth rates and multiple birth rates with 1 embryo transferred over 2 cycles vs 2 embryos in 1 cycle.Impact of obesity on infertility in women.Effect of Obesity on the Preovulatory Follicle and Lipid Fingerprint of Equine Oocytes.Predictors of pregnancy and live birth after insemination in couples with unexplained or male-factor infertilityDirect effects of leptin and adiponectin on peripheral reproductive tissues: a critical review.Insulin-stimulated glucose uptake occurs in specialized cells within the cumulus oocyte complex.Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes.Incorporating patient preference into the management of infertility in women with polycystic ovary syndrome.Body mass index and short-term weight change in relation to treatment outcomes in women undergoing assisted reproductionMen's body mass index in relation to embryo quality and clinical outcomes in couples undergoing in vitro fertilization.Cumulative birth rates with linked assisted reproductive technology cyclesSirt3 prevents maternal obesity-associated oxidative stress and meiotic defects in mouse oocytes.Use of gonadotropin-releasing hormone agonist trigger during in vitro fertilization is associated with similar endocrine profiles and oocyte measures in women with and without polycystic ovary syndrome.Maternal obesity, infertility and mitochondrial dysfunction: potential mechanisms emerging from mouse model systems.Effect of body mass index and age on in vitro fertilization in polycystic ovary syndrome.IVF outcomes in obese donor oocyte recipients: a systematic review and meta-analysis.DHEA-mediated inhibition of the pentose phosphate pathway alters oocyte lipid metabolism in mice.Low-Dose Urinary Human Chorionic Gonadotropin Is Effective for Oocyte Maturation in In Vitro Fertilization/ Intracytoplasmic Sperm Injection Cycles Independent of Body Mass Index.Complications and outcome of assisted reproduction technologies in overweight and obese women.Epigenetic Influences During the Periconception Period and Assisted Reproduction.Urinary triclosan concentrations and diminished ovarian reserve among women undergoing treatment in a fertility clinic.Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.Reproductive outcomes in oocyte donation cycles are associated with donor BMI.Gestational carrier BMI and reproductive, fetal and neonatal outcomes: are the risks the same with increasing obesity?
P2860
Q23920160-A7A16A99-07CE-472B-8A30-3B16010FB05EQ26779477-5EC45D3D-E91A-43C4-AC26-CEE846ACAB26Q27023149-5B6AEAE9-46B5-4B05-A62F-5650945A1615Q27026624-65C88FEC-EA45-4652-97E5-3F3D94699790Q28393714-51080214-05AA-48AB-A8B4-B42254607721Q30352472-56387285-F3C6-45B3-8943-6384A6C1A556Q33566968-99468E90-17D8-43C5-82C0-B917896A24D0Q33636667-33957776-4262-49DE-873B-74AE73A869A1Q33701382-A497086E-93A5-4CFA-930F-38CEE34F4868Q33807451-B2A1EC3C-CD9C-4C73-8759-125C59691921Q34300915-328E6E5E-9067-439C-B2C2-D944AAA837FAQ34645192-DCA8B4CA-E893-4546-AB6A-D88FA7F0403AQ34766224-0DEC88BD-1A31-4B2F-9D20-73FA60C19B38Q35100089-B9493B9D-2F28-457E-9554-CF826446F722Q35171112-6158D00F-2A46-410C-A7EF-FD3C815B8639Q35318639-2305D44B-24D7-4183-9899-3767FA5DA90FQ35561404-E030FFF2-BFB7-47DC-BB99-10B46FA79857Q35686944-AA4BE8B5-218E-4352-A90E-09B150D1162DQ35859764-DE8DFBDB-8718-4ADD-AE4B-216D566B165FQ35869938-17DDAFEE-AA63-48A2-B2ED-182D312E1990Q35897949-D663847A-DE7E-4289-9B5D-57E421270267Q35920750-3A2BC902-CE8C-469D-B00B-1932B6FA181AQ35946314-69FFE336-8E4F-4757-8274-6ADAE1ADA698Q36048415-908872F2-F2B8-405D-A4D4-A3285BF73DEAQ36074371-3762766F-9EA0-49AB-B0E3-EDD83B3443F0Q36339079-B4363B03-AB84-4D4A-864F-CF45EBA00FB2Q36758614-05F9AFB7-551F-416A-AD86-F5DCAD05E44CQ36780684-E9198C24-FCCE-4CB1-98A2-F1D4F952032CQ36900329-B52D64F1-ED15-41DD-A957-45CCDE793E3EQ37016875-5449C184-F9D2-4BA7-9C37-B2D063CECF11Q37042367-52B24717-7A4D-4F6E-9F6D-BFDD5BAE4728Q37183931-C93ACFC0-2808-4EFF-B9F8-27D698BD920BQ37331038-83A2E01B-0FF8-4A50-8FB6-85B5F79DBCB1Q37561768-752AF9C6-C617-4028-AC1F-CA426833D251Q37965116-D7C2DADB-0206-4CE4-AD48-C0FB82854905Q38634063-AE6117F9-ECB9-45CE-9F53-085EC24229DBQ38742444-46AB9F5E-47C3-434A-A8D1-DE671D2914B1Q38994475-4EABEAAF-A161-4A7F-AEAB-6C8C8693692FQ40201408-FFA83E85-C171-427E-BB1F-FC467F9A75BEQ40625685-3FB4CCA6-801F-44E0-A480-C94E67F63FB4
P2860
Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Female obesity adversely affec ...... regnancy and live birth rates.
@en
Female obesity adversely affects assisted reproductive technology
@nl
type
label
Female obesity adversely affec ...... regnancy and live birth rates.
@en
Female obesity adversely affects assisted reproductive technology
@nl
prefLabel
Female obesity adversely affec ...... regnancy and live birth rates.
@en
Female obesity adversely affects assisted reproductive technology
@nl
P2093
P2860
P356
P1433
P1476
Female obesity adversely affec ...... regnancy and live birth rates.
@en
P2093
Barbara Luke
Judy E Stern
Morton B Brown
Richard Leach
SART Writing Group
Victor Y Fujimoto
P2860
P304
P356
10.1093/HUMREP/DEQ306
P407
P577
2010-11-11T00:00:00Z